227
Views
15
CrossRef citations to date
0
Altmetric
Clinical Features

COPD and Associated Comorbidities: A Review of Current Diagnosis and Treatment

, MD, FCCP, MAACVPR, FAARC
Pages 225-240 | Published online: 13 Mar 2015

References

  • . Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org. Updated December 2011. Accessed June 26, 2012
  • . Menzin J, Boulanger L, Marton J, . The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population. Respir Med. 2008;102(9):1248–1256
  • . National Heart, Lung, and Blood Institute. Morbidity and mortality: 2009 chartbook on cardiovascular, lung, and blood diseases. Washington, DC: US Dept of Health and Human Services, Public Health Service, National Institutes of Health; 2009
  • . Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10): 847–852
  • . Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003;58(7):589–593
  • . Jones PW, Brusselle G, Dal Negro RW, . Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105(1):57–66
  • . Anderson G. Chronic care: making the case for ongoing care. Princeton, NJ: Robert Wood Johnson Foundation. http://www.rwjf.org/files/research/50968chronic.care.chartbook.pdf. Accessed June 2011
  • . Martinez FJ, Raczek AE, Seifer FD, ; COPD-PS Clinician Working Group. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85–95
  • . Yawn BP, Mapel DW, Mannino DM, ; Lung Function Questionnaire Working Group. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010;5:1–10
  • . ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD. 2007;4(3):293–297
  • . O'Donnell DE, Hernandez P, Kaplan A, . Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008;15( suppl A):1A–8A
  • . American Thoracic Society and European Respiratory Society. Standards for the diagnosis and management of patients with COPD. New York/Lausanne, Switzerland. http://www.copd-ats-ers.org/copddoc.pdf. Accessed May 2010
  • . Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117(4):1146–1161
  • . Bateman E, Boulet L, Cruz A, . Pocket guide for asthma prevention (for adults and children older than 5 years). A pocket guide for physicians and nurses. http://www.ginasthma.org/pdf/GINA_Pocket_2010a.pdf. Last updated 2010. Accessed September 28, 2011
  • . Management of Asthma Working Group. VA/DoD clinical practice guideline for management of asthma in children and adults. Washington, DC: Department of Veterans Affairs, Department of Defense; 2009. http://www.guideline.gov/content.aspx?id=15706. Last updated 2009. Accessed September 28, 2011
  • . Tinkelman DG, Price DB, Nordyke RJ, . Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006;73(3):296–305
  • . McGoon M, Gutterman D, Steen V, ; American College of Chest Physicians. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126( 1 suppl):14S–34S
  • . Rich S. Primary pulmonary hypertension: executive summary from the World Symposium on Primary Pulmonary Hypertension. Evian, France: World Health Organization; 1998. http://www.who.int/ncd/cvd/pph.html. Accessed March 1, 2011
  • . Qaseem A, Snow V, Barry P, ; Joint American Academy of Family Physicians/American College fo Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Fam Med. 2007;5(1):57–62
  • . Torbicki A, Perrier A, Konstantinides S, ; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276–2315
  • . American College of Chest Physicians. Lung cancer…am I at risk? Patient education guide. Northbrook, IL. http://accpstorage.org/newOrganization/patients/lungCancer5045.pdf. Accessed February 24, 2011
  • . National Guideline Clearinghouse (NGC-5930). Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines. Rockville, MD: US Department of Health and Human Services; 2007. http://www.guideline.gov/content.aspx?id=11411&search=lung+cancer. Accessed January 10, 2011
  • . Antman EM, Cohen M, Bernink PJ, . The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–842
  • . National Guideline Clearinghouse (NGC-7228). Coronary artery disease (CAD) clinical practice guidelines. Oakland, CA: Kaiser Permanente Care Management Institute; 2008. http://www.guideline.gov/content.aspx?id=14438. Accessed March 2, 2011
  • . Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847
  • . Wijeysundera HC, Tomlinson G, Norris CM, Ghali WA, Ko DT, Krahn MD. Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework. Med Decis Making. 2011;31(3):481–493
  • . National Guideline Clearinghouse (NGC-8088). Institute for Clinical Systems Improvement guidelines for diagnosis and management of type 2 diabetes mellitus in adults. Bloomington, MN: US Dept of Health and Human Services; 2010. http://www.guideline.gov/content.aspx?id=24137. Last updated 2010. Accessed February 28, 2011
  • . US Preventive Services Task Force. Screening for peripheral arterial disease: recommendation statement. Am Fam Physician. 2006;73(3):497–500
  • . Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45(10):1101–1109
  • . Rutten FH, Cramer MJ, Grobbee DE, . Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005;26(18):1887–1894
  • . Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston, MA: Little, Brown, and Co; 2011. http://www.americanheart.org/. Accessed February 28, 2011
  • . Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49(2):171–180
  • . National Guideline Clearinghouse (NGC-7986). Heart failure in patients with reduced ejection fraction: HFSA 2010 comprehensive heart failure practice Guideline. Rockville, MD: US Department of Health and Human Services; 2010. http://www.guideline.gov/content.aspx?id=23903&search=heart+failure. Accessed January 8, 2011
  • . Management of Overweight and Obesity Working Group. VA/DoD clinical practice guideline for screening and management of overweight and obesity. Washington, DC: Department of Veterans Affairs, Department of Defense; 2006. http://www.guideline.gov/content.aspx?id=10714. Accessed September 28, 2011
  • . Rosenzweig JL, Ferrannini E, Grundy SM, ; Endocrine Society. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(10):3671–3689
  • . Heikes KE, Eddy DM, Arondekar B, Schlessinger L. Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes. Diabetes Care. 2008;31(5):1040–1045
  • . Celli BR, Cote CG, Marin JM, . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012
  • . Benton MJ, Wagner CL, Alexander JL. Relationship between body mass index, nutrition, strength, and function in elderly individuals with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2010;30(4):260–263
  • . Anker SD, Laviano A, Filippatos G, . ESPEN guidelines on parenteral nutrition: on cardiology and pneumology. Clin Nutr. 2009;28(4):455–460
  • . Anker SD, John M, Pedersen PU, . ESPEN guidelines on enteral nutrition: cardiology and pulmonology. Clin Nutr. 2006; 25(2):311–318
  • . National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010. http://www.nof.org/sites/default/files/pdfs/NOF_ClinicianGuide2009_v7.pdf. Accessed August 31, 2010
  • . Kanis JA. FRAX® WHO fracture risk assessment tool. http://www.shef.ac.uk/FRAX/index.jsp. Accessed March 3, 2008
  • . Adshead F, Cody DD, Pitt B. BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ. 1992; 305(6850):397
  • . Kunik ME, Azzam PN, Souchek J, . A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics. 2007;48(1):16–21
  • . Incalzi RA, Corsonello A, Pedone C, Corica F, Carbonin P, Bernabei R. Construct validity of activities of daily living scale: a clue to distinguish the disabling effects of COPD and congestive heart failure. Chest. 2005;127(3):830–838
  • . Folstein MF, Folstein SE, McHugh PR. “Mini—mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198
  • . Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–65
  • . National Guideline Clearinghouse (NGC-6350). Assessing cognitive function. In: Evidence-based geriatric nursing protocols for best practice. New York, NY: Springer Publishing Company; 2008. http://www.guideline.gov/content.aspx?id=12266. Accessed February 28, 2011
  • . Rascon—Aguilar IE, Pamer M, Wludyka P, Cury J, Vega KJ. Poorly treated or unrecognized GERD reduces quality of life in patients with COPD. Dig Dis Sci. 2011;56(7):1976–1980
  • . Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112(5):1448–1456
  • . Institute for Clinical Systems Improvement. Major depression in adults in primary care. 14th ed. Bloomington, MN: Institute for Clinical Systems Improvement. http://www.icsi.org/depression_5/depression__major__in_adults_in_primary_care_3.html. Last updated May 2011. Accessed July 29, 2011
  • . National Guideline Clearinghouse (NGC-8118). Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). Bloomington, MN: Institute for Clinical Systems Improvement; 2010. http://www.guideline.gov/content.aspx?id=24215&search=diagnosis+and+treatment+of+chest+pain+and+acute+coronary+syndrome. Accessed March 4, 2011
  • . Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest. 2006;129( 1 suppl):80S–94S
  • . Global Initiative for Asthma. Pocket guide for asthma prevention (for adults and children older than 5 years). Global Initiative for Asthma; 2010. http://www.ginasthma.org/pdf/GINA_Pocket_2010a.pdf. Accessed January 28, 2011
  • . Casaburi R. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2001;33( 7 suppl): S662–S670
  • . Meador BM, Huey KA. Statin-associated myopathy and its exacerbation with exercise. Muscle Nerve. 2010;42(4):469–479
  • . Screening for peripheral arterial disease: recommendation statement. Am Fam Physician. 2006;73(3):497–500
  • . Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010;137(2):341–347
  • . Kulak CA, Borba VC, Jorgetti V, . Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease. J Bone Miner Res. 2010;25(9):1931–1940
  • . Spiriva HandiHaler [package insert]. Ridgefield, CT: Boehringer Ingelheim. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Spiriva/Spiriva.pdf. Last updated June 2010. Accessed February 17, 2011
  • . Advair Diskus/Advair [package insert]. Research Triangle Park, NC: GlaxoSmithKline Inc. http://us.gsk.com/products/assets/us_advair.pdf. Last updated June 2010. Accessed February 17, 2011
  • . Ries AL, Bauldoff GS, Carlin BW, . Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131( 5 suppl):4S–42S
  • . Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93(3):391–398
  • . Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT). Part II: lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med. 2011;184(8):881–893
  • . Todd JL, Palmer SM. Lung transplantation in advanced COPD: is it worth it? Semin Respir Crit Care Med. 2010;31(3):365–372
  • . Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212
  • . Benzo R, Wigle D, Novotny P, . Preoperative pulmonary rehabilitation before lung cancer resection: Results from two randomized studies. Lung Cancer. 2011;74(3):441–445
  • . Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician. 2001;63(9):1789–1798
  • . Macnee W. Right heart function in COPD. Semin Respir Crit Care Med. 2010;31(3):295–312
  • . Lee R, McNicholas WT. Obstructive sleep apnea in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2011;17(2):79–83
  • . Crowley K. Sleep and sleep disorders in older adults. Neuropsychol Rev. 2011;21(1):41–53
  • . Dancey DR, Hanly PJ, Soong C, Lee B, Shepard J Jr, Hoffstein V. Gender differences in sleep apnea: the role of neck circumference. Chest. 2003;123(5):1544–1550
  • . Soler—Cataluña JJ, Martinez—García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931
  • . Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 pt 1):1418–1422
  • . Niewoehner DE. The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Med. 2002;1(4):243–248
  • . Calverley PM, Anderson JA, Celli B, ; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789
  • . Hurst JR, Vestbo J, Anzueto A, ; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138
  • . Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–1097
  • . Gupta P, O'Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Drugs Aging. 2008;25(5):415–443
  • . Tashkin DP, Celli B, Senn S, ; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554
  • . Michele TM, Pinheiro S, Iyasu S. The safety of tiotropium—the FDA's conclusions. N Engl J Med. 2010;363(12):1097–1099
  • . Benson MK, Berrill WT, Cruickshank JM, Sterling GS. A comparison of four beta-adrenoceptor antagonists in patients with asthma. Br J Clin Pharmacol. 1978;5(5):415–419
  • . Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 2009; 11(12):1182–1188
  • . Bashore TM, Granger CB, Hranitzky P, . Congestive heart failure. In: McPhee SJ, Papadakis MA, Rabow MW, eds. Current Medical Diagnosis and Treatment 2011. New York, NY: Lange Medical Books/McGraw-Hill; 2011:317–325
  • . Kannel WB, Seidman JM, Fercho W, Castelli WP. Vital capacity and congestive heart failure. The Framingham study. Circulation. 1974;49(6):1160–1166
  • . LeGatt DF. Theophylline toxicity—a consequence of congestive heart failure. Drug Intell Clin Pharm. 1983;17(1):59–60
  • . Edner M, Jogestrand T, Dahlqvist R. Effect of salbutamol on digoxin pharmacokinetics. Eur J Clin Pharmacol. 1992;42(2):197–201
  • . Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969
  • . Loukides S, Polyzogopoulos D. The effect of diabetes mellitus on the outcome of patients with chronic obstructive pulmonary disease exacerbated due to respiratory infections. Respiration. 1996;63(3):170–173
  • . van der Molen T. Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences. Prim Care Respir J. 2010;19(4):326–334
  • . Howard C, Dupont S, Haselden B, Lynch J, Wills P. The effectiveness of a group cognitive-behavioural breathlessness intervention on health status, mood and hospital admissions in elderly patients with chronic obstructive pulmonary disease. Psychol Health Med. 2010;15(4):371–385
  • . Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ. 2002;51(6):1–16
  • . Crisafulli E, Gorgone P, Vagaggini B, . Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J. 2010;36(5):1042–1048
  • . Hanania NA, Sharma G, Sharafkhaneh A. COPD in the elderly patient. Semin Respir Crit Care Med. 2010;31(5):596–606
  • . Biskobing DM. COPD and osteoporosis. Chest. 2002;121(2):609–620
  • . Kanis JA, Johnell O, Oden A, . Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155–162
  • . National Guideline Clearinghouse (NGC-5852). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Prevention of type 2 diabetes mellitus. US Dept of Health and Human Services. http://www.guideline.gov/content.aspx?id=11093&search=diabetes. Accessed January 10, 2011
  • . National Guideline Clearinghouse (NGC-7985). Nonpharmacologic management and health care maintenance of patients with chronic heart failure: HFSA 2010 comprehensive heart failure practice guideline. St. Paul, MN: Heart Failure Society of America. http://www.guideline.gov/content.aspx?id=23902. Last updated June 2010. Accessed March 4, 2011
  • . Couillard A, Muir JF, Veale D. COPD recent findings: impact on clinical practice. COPD. 2010;7(3):204–213
  • . Sava F, Laviolette L, Bernard S, Breton MJ, Bourbeau J, Maltais F. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010;10:55
  • . Evans RA, Singh SJ, Collier R, Loke I, Steiner MC, Morgan MD. Generic, symptom based, exercise rehabilitation; integrating patients with COPD and heart failure. Respir Med. 2010;104(10):1473–1481
  • . Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B. Innovations to achieve excellence in COPD diagnosis and treatment in primary care. Postgrad Med. 2010;122(5):150–164
  • . National Committee for Quality Assurance. PCMH 2011 Standards. Washington, DC: National Committee for Quality Assurance; 2011
  • . Steinhauser KE, Arnold RM, Olsen MK, . Comparing three life-limiting diseases: does diagnosis matter or is sick, sick? J Pain Symptom Manage. 2011;42(3):331–341
  • . Katz P, Morris A, Gregorich S, . Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions. J Clin Epidemiol. 2009;62(2):158–166
  • . Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571–584
  • . Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50(10):1313–1321; discussion 1321–1312
  • . Melani AS, Bracci LS, Rossi M. Reduced peak inspiratory effort through the Diskus((R)) and the Turbuhaler((R)) due to mishandling is common in clinical practice. Clin Drug Investig. 2005; 25(8):543–549
  • . Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing. 2007;36(2):213–218
  • . Gooneratne NS, Patel NP, Corcoran A. Chronic obstructive pulmonary disease diagnosis and management in older adults. J Am Geriatr Soc. 2010;58(6):1153–1162
  • . Steinman MA, Hanlon JT. Managing medications in clinically complex elders: “There's got to be a happy medium.” JAMA. 2010;304(14):1592–1601
  • . Kronman AC, Ash AS, Freund KM, Hanchate A, Emanuel EJ. Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med. 2008;23(9): 1330–1335
  • . Castaldi PJ, Rogers WH, Safran DG, Wilson IB. Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease. Chest. 2010;138(3):614–620
  • . Lanken PN, Terry PB, Delisser HM, ; ATS End-of-Life Care Task Force. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med. 2008;177(8):912–927

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.